Industry News
Research, Science & Manufacturer Updates
The Centers for Medicare and Medicaid Services has delayed enforcement of a rule that changes the way state Medicaid agencies reimburse pharmacies for prescription drugs.
The U.S. Department of Health and Human Services has awarded $94 million in Affordable Care Act funding to 271 health centers in 45 states, the District of Columbia and Puerto Rico.
The Centers for Medicare and Medicaid Services announced 10 states in four regions in which it will launch its primary care quality improvement initiative.
The National Institutes of Health will spend $260 million over four years to fund four genome sequencing and analysis centers whose research is expected to focus on understanding the genomic bases of common and rare human diseases.
Three health centers in America Samoa and the U.S. Virgin Islands and their 12 delivery sites that served nearly 26,000 patients in 2014, including more than 6,000 women ages 15 years to 45 years, have been awarded $742,000 in funding to fight the Zika virus.
The U.S. Senate approved the Medicare “lock-in” provision that gives Medicare Part D plans the authority to require at-risk beneficiaries to use a single prescriber and pharmacy for frequently abused drugs.
Empliciti (elotuzumab) in combination with Revlimid (lenalidomide) and dexamethasone (a type of corticosteroid) has been approved by the U.S. Food and Drug Administration to treat individuals with multiple myeloma who have received one to three prior medications.
The Centers for Medicare and Medicaid Services will implement a new primary care payment model affecting up to 5,000 practices and more than than 20,000 clinicians.
The Centers for Medicare and Medicaid Services issued a final rule mandating prior authorization for durable medical equipment.
A new study found that seasonal flu vaccines work better if they stimulate an immune response to the flu surface protein neuraminidase.
Two young adult male dogs with severe hemophilia A treated with liver-targeted gene therapy experienced significant improvement in disease phenotype over follow-up periods of 31 months and 24 months, according to investigators at The Children’s Hospital of Philadelphia and the University of Pennsylvania.
The Medicare Rights Center has launched Medicare Interactive (MI), a free online resource with hundreds of answers to Medicare questions.